ClinConnect ClinConnect Logo
Search / Trial NCT05990790

The Effect of Desflurane Versus Sevoflurane Versus Propofol on Postoperative Delirium

Launched by MEDICAL UNIVERSITY OF VIENNA · Aug 11, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Propofol Sevoflurane Desflurane

ClinConnect Summary

This clinical trial is studying how different types of anesthesia—desflurane, sevoflurane, and propofol—affect the likelihood of developing postoperative delirium in older patients after major noncardiac surgeries. Postoperative delirium is a condition that can cause confusion and memory problems in patients over 65, and preventing it is very important for their recovery. The researchers are especially interested in whether desflurane, which works more quickly than the other two anesthetics, can help lower the risk of this condition.

To participate in this trial, you need to be at least 65 years old and scheduled for an elective surgery that will take at least two hours. You must also be able to give written consent to join the study. However, if you have certain health conditions—like a history of dementia, certain muscle disorders, or if you're undergoing emergency surgery—you would not be eligible. Participants will receive one of the three types of anesthesia during surgery and will be monitored afterward to see if they experience delirium. This research could help doctors understand how to better care for elderly patients undergoing major surgeries.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Provide written informed consent
  • ≥65 years of age
  • Scheduled for elective major noncardiac surgery with estimated time of surgery ≥ 2 hours
  • Exclusion Criteria:
  • Patients undergoing emergency surgery
  • BMI \> 45 kg/m\^2
  • History of diagnosed dementia
  • Language, vision, or hearing impairments that may compromise cognitive assessments
  • History of malignant hyperthermia
  • History of structural muscle disease
  • History of organ transplantation (kidney, liver, lung, heart)
  • Patients undergoing hyperthermic intraperitoneal chemotherapy
  • ICU patients undergoing surgery

About Medical University Of Vienna

The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.

Locations

Vienna, , Austria

Innsbruck, , Austria

Patients applied

0 patients applied

Trial Officials

Christian Reiterer, Prof. MD

Principal Investigator

Medical University of Vienna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported